Mengdan Xu
- Molecular Biology
- Oncology top 10%
- Cancer Research top 10%
- Immunology
- Pulmonary and Respiratory Medicine
- Co-authors
- Shenglong LiMengyao WuFei‐Ran GongYan ZhangMeng ShenJessica RobinMin TaoMin Jiang
- Topics
- Inflammatory Biomarkers in Disease Prognosis (10 papers)Cancer Immunotherapy and Biomarkers (5 papers)Cancer, Lipids, and Metabolism (5 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Mengdan Xu
61 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 127
- Molecular Biology 458
- Oncology 281
- Cancer Research 211
- Immunology 145
- Pulmonary and Respiratory Medicine 142
Countries citing papers authored by Mengdan Xu
This map shows the geographic impact of Mengdan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengdan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengdan Xu more than expected).
Fields of papers citing papers by Mengdan Xu
This network shows the impact of papers produced by Mengdan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengdan Xu. The network helps show where Mengdan Xu may publish in the future.
Co-authorship network of co-authors of Mengdan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Mengdan Xu. A scholar is included among the top collaborators of Mengdan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengdan Xu. Mengdan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 9 | |
| 4 | 73 | |
| 5 | 16 | |
| 6 | 4 | |
| 7 | 7 | |
| 8 | 0 | |
| 9 | 9 | |
| 10 | 25 | |
| 11 | 5 | |
| 12 | 7 | |
| 13 | 6 | |
| 14 | 39 | |
| 15 | 13 | |
| 16 | 1 | |
| 17 | 28 | |
| 18 | 10 | |
| 19 | 61 | |
| 20 | 3 |
About Mengdan Xu
Mengdan Xu is a scholar working on Cancer Research, Oncology and Internal Medicine, having authored 65 papers that have together received 1.1k indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (10 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer, Lipids, and Metabolism (5 papers). The work is most often cited by research in Cancer Research (211 citations), Oncology (281 citations) and Immunology (145 citations). Mengdan Xu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Shenglong Li, Mengyao Wu, Fei‐Ran Gong, Yan Zhang, Meng Shen, Jessica Robin, Min Tao, Min Tao, Min Jiang and Qiaoming Zhi. Their work appears in journals such as Blood, The American Journal of Gastroenterology and Acta Biomaterialia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.